OMB APPROVAL
OMB NUMBER 3235-0058
EXPIRES: MAY 31, 1997
Estimated average burden
hour per response....2.50
0-11480
CUSIP NUMBER
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
Form 10-K Form 20-F Form 11-K X Form 10-Q Form N-SAR
--- --- --- --- ---
For Period Ended: June 30, 2000
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:_________________________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
----------------------------------------------------------------------------
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing check above, identify the
Item(s) to which the notification relates:
PART I -- REGISTRANT INFORMATION
Full Name of Registrant
CELLEX BIOSCIENCES, INC.
Former Name if Applicable
---------------------------------
Address of Principal Executive Office (Street and Number)
8500 Evergreen Blvd
Coons Rapids, MN 55433
<PAGE>
PART II -- RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate).
|X| (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
|X| (b) The subject annual report, semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will
be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report of transition
report on Form 10-Q, or portion thereof will be filed on or before the
fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
On August 3, 2000 we wrote to Ms. Kate Nix at EDGAR requesting an extension of
the continuing hardship exemption granted to us on January 7, 2000.
Our request was denied on August 8, 2000. We immediately filed form TH
allowing six days to file the Form 8-K/A on EDGAR. Our limited resources have
been devoted to that filing at the expense of our 10Q filing for the period
ended June 30,2000. We respectfully request a 12b-25 extension to our filing
of the 10Q due today.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Thomas F. Belleau 201 816-8900
----------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If answer is not, identify report(s), X Yes No
--- ---
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or
portion thereof? Yes X No
--- ---
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
<PAGE>
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: August 14, 2000 By: /s/ Thomas F. Belleau
--------------- ------------------------------------------
Thomas F. Belleau, Chief Financial Officer
